These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6641123)
61. High concentrations of N-terminal peptide of type III procollagen in the sera of patients with various cancers, with special reference to liver cancer. Hatahara T; Igarashi S; Funaki N Gan; 1984 Feb; 75(2):130-5. PubMed ID: 6735030 [TBL] [Abstract][Full Text] [Related]
62. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum. Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159 [TBL] [Abstract][Full Text] [Related]
63. Increased serum procollagen III aminoterminal peptide in myelofibrosis. Hochweiss S; Fruchtman S; Hahn EG; Gilbert H; Donovan PB; Johnson J; Goldberg JD; Berk PD Am J Hematol; 1983 Dec; 15(4):343-51. PubMed ID: 6650494 [TBL] [Abstract][Full Text] [Related]
64. Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease. Weigand K; Zaugg PY; Frei A; Zimmermann A Hepatology; 1984; 4(5):835-8. PubMed ID: 6479852 [TBL] [Abstract][Full Text] [Related]
65. The carboxyterminal propeptide of procollagen type I (PICP) in serum and biological fluids. Risteli L Scand J Clin Lab Invest Suppl; 1990; 202():143-6. PubMed ID: 2075430 [No Abstract] [Full Text] [Related]
66. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation. Linkhart SG; Linkhart TA; Taylor AK; Wergedal JE; Bettica P; Baylink DJ Clin Chem; 1993 Nov; 39(11 Pt 1):2254-8. PubMed ID: 8222218 [TBL] [Abstract][Full Text] [Related]
67. Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NC1) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease. Hayasaka A; Schuppan D; Ohnishi K; Okuda K; Hahn EG J Hepatol; 1990 Jan; 10(1):17-22. PubMed ID: 2307825 [TBL] [Abstract][Full Text] [Related]
68. Comparison of assays for N-amino terminal propeptide of type III procollagen in chronic hepatitis C by using receiver operating characteristic analysis. Walsh KM; Fletcher A; MacSween RN; Morris AJ Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):827-31. PubMed ID: 10514112 [TBL] [Abstract][Full Text] [Related]
69. Laminin and aminoterminal propeptide of type III procollagen in seminal plasma from fertile and vasectomized men. Geipel U; Kropf J; Bürgi W; Gressner AM Andrologia; 1993; 25(4):217-21. PubMed ID: 8352431 [TBL] [Abstract][Full Text] [Related]
70. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV. Dyne KM; Zanaboni G; Annoni G; De Agostini MP; Cetta G Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053 [TBL] [Abstract][Full Text] [Related]
71. Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients. Tanaka Y; Minato Y; Hasumura Y; Takeuchi J Dig Dis Sci; 1986 Jul; 31(7):712-7. PubMed ID: 3720468 [TBL] [Abstract][Full Text] [Related]
72. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon. Gabrielli GB; Casaril M; Stanzial AM; Colombari R; Pasino M; Corrocher R Hepatogastroenterology; 2003; 50(54):2017-21. PubMed ID: 14696456 [TBL] [Abstract][Full Text] [Related]
73. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis. Risteli J; Søgaard H; Oikarinen A; Risteli L; Karvonen J; Zachariae H Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204 [TBL] [Abstract][Full Text] [Related]
74. Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histology. Trinchet JC; Hartmann DJ; Pateron D; Munz-Gotheil C; Callard P; Ville G; Beaugrand M Alcohol Clin Exp Res; 1992 Apr; 16(2):342-6. PubMed ID: 1590556 [TBL] [Abstract][Full Text] [Related]
75. [Measurement of serum concentration with radioimmunoassay for carboxyterminal propeptide of type 1 procollagen]. Yamamoto I; Takada M; Ohnaka Y; Yuu I; Yamamoto Y; Hamazu H; Morita R Kaku Igaku; 1993 May; 30(5):563-9. PubMed ID: 8336416 [TBL] [Abstract][Full Text] [Related]
76. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of high-risk pregnancies: a biochemical approach to the dynamic assessment of deviant fetal growth. Vanhaesebrouck P; Kint J; Van Kets H; Govaert P; Smets K; Defoort P; Leroy J Pediatr Res; 1994 Jul; 36(1 Pt 1):71-6. PubMed ID: 7936841 [TBL] [Abstract][Full Text] [Related]
77. Procollagen-type III-peptide serum concentrations in chronic persistent and chronic active hepatitis and in cirrhosis of the liver and their diagnostic value. Raedsch R; Stiehl A; Waldherr R; Mall G; Gmelin K; Götz R; Walker S; Czygan P; Kommerell B Z Gastroenterol; 1982 Dec; 20(12):738-43. PubMed ID: 7164528 [TBL] [Abstract][Full Text] [Related]
79. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen. Maurice PD; Maddox AJ; Green CA; Tatnall F; Schofield JK; Stott DJ Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813 [TBL] [Abstract][Full Text] [Related]
80. Serum procollagen type III peptide levels in patients with acute viral hepatitis. Annoni G; Donato MF; Cantaluppi C; Lampertico P; Cargnel A; Viganò P; Hahn EG; Colombo M Ric Clin Lab; 1988; 18(1):37-44. PubMed ID: 3375738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]